# Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome

> **NCT04818723** · NA · COMPLETED · sponsor: **Nishtar Medical University** · enrollment: 106 (actual)

## Conditions studied

- Nephrotic Syndrome

## Interventions

- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT04818723
- **Lead sponsor:** Nishtar Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2020-05-30
- **Final completion:** 2020-05-30
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818723, "Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04818723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*